IFNG and neoplasm: The incorporation of IL-12 into the SV vector enhanced the therapeutic effect by inducing IFNγ secretion from NK cells, which was shown to upregulate the expression of MHC class II on peritoneal macrophages promoting an M1 anti-tumor effect.